Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.
about
Omega 3 fatty acids for the treatment of dementia and cognitive impairmentOmega-3 fatty acids: potential role in the management of early Alzheimer's diseaseInsight into the Molecular Imaging of Alzheimer's DiseaseRole of docosahexaenoic acid in the modulation of glial cells in Alzheimer's diseaseDocosahexaenoic Acid and Cognition throughout the LifespanDiet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional InterventionsMaintenance of synaptic stability requires calcium-independent phospholipase A₂ activityEffects of N-3 Polyunsaturated Fatty Acids on DementiaOmega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's DiseaseMeasurement error adjustment in essential fatty acid intake from a food frequency questionnaire: alternative approaches and methods.Zinc and DHA have opposing effects on the expression levels of histones H3 and H4 in human neuronal cells.Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patientsAPOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.Omega-3 fatty acids and dementia.Omega-3 fatty acids and cognitive function in women.Randomized controlled trial examining the effects of fish oil and multivitamin supplementation on the incorporation of n-3 and n-6 fatty acids into red blood cells.Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthoodEffects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial.Peroxisomal alterations in Alzheimer's diseaseShort-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus.Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA?Aging decreases rate of docosahexaenoic acid synthesis-secretion from circulating unesterified α-linolenic acid by rat liverDocosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse modelCharacterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA.Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations.Omega-3 fatty acids EPA and DHA: health benefits throughout life.DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effectsPathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmissionImaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.Dietary antioxidant intake and its association with cognitive function in an ethnically diverse sample of US adults.Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats.Differences in the skeletal muscle transcriptome profile associated with extreme values of fatty acids contentPlasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's DiseaseAssessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human agingTranslational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo.
P2860
Q24234477-7A6FD064-542F-4AA1-BEE5-BEAED01D1A85Q24595490-7B60A627-5DF2-4487-A076-7951D1BDCE77Q26765945-08DE187B-A46F-4DE9-8936-C99B7AF9706BQ26766462-570E1AB4-9A59-4B30-95F7-C16E296666DFQ26768442-C951B895-FEB0-4D3B-A916-D427FB08F1ECQ26798129-13178806-9719-4AAE-9C33-4ED956D453B1Q27027705-4EC1E9A5-DC62-44A2-9E35-3A7BEDB44658Q28075307-0E6FE477-A396-437A-BD59-D9A31A03F463Q28080464-20B15AE0-13F8-4D15-81E4-664E615AFBF8Q33299024-79A33658-B6F6-478E-B115-B9530BC5A219Q33502386-3E08AA8D-EA9C-4326-BF00-9A82B829402BQ33563175-A7CB115E-BFC3-48C6-845E-9B1590AB1826Q33563660-865BAFFA-EBFE-4752-94FA-6A9D793F6F6BQ33602402-87AAB795-675B-478C-841D-45AAC8CB9171Q33677382-02C4CEC3-C680-40CB-A09A-9B1AFE9B63C3Q33701569-88A1E6DE-DC8A-4B35-BF83-ADC5942D10B6Q33821703-D35F9BC3-A912-40C3-93DB-4DA2CE795E79Q33873381-943ADC81-7664-4FED-8CE8-CE3B73DDD81EQ33905478-FB027E8D-CA68-40B7-B613-C989401171C0Q34175004-C67CC441-191D-412C-86E8-2D99B5FEDC4CQ34256938-4A569F30-D0BC-4838-9E22-F4D8ED86A003Q34258505-4BF39C71-7126-4D9D-B394-0BBD4F719F57Q34344634-204C84AC-CE61-4467-AFF6-0069D68410F7Q34349017-0E86CB12-CFFF-4672-B631-37117F88352BQ34583573-A6C8B212-DE55-4828-9E9A-35748D72131EQ34635830-1B91F95D-7740-4B9F-8E31-9CB7F76075E7Q35053868-F012CBC2-494B-478A-A1AA-22116981C6AEQ35117457-5649A771-86D1-447E-9916-258ACEC9358DQ35179546-248DE38D-02D5-4545-A4B1-3297C73DAEE7Q35218379-27220D51-E0C5-4A8A-81C7-0EA6540FDED4Q35448857-FF65B02F-176E-4A68-94B8-AE2B2615CD6AQ35742545-ABF5AD38-D3FB-472B-8B83-2B382B798A8BQ35838808-60482696-0A2D-49B5-BDD6-1F92C3D624F1Q36132033-4FCCBF81-7052-484A-9E8C-19EE940D574DQ36134538-A7A195A7-68CB-40E6-AF08-79BAC4CF0600Q36167890-A0B6F229-03AD-4341-B0D0-E0450FD35B24Q36201368-A34BA55F-81F9-441E-BBDC-6F7C37F70572Q36272443-DCC44284-A63C-4D80-BB6F-A1859C3B7916Q36272892-64E2BF5D-EA87-4B4B-8E04-3B71AE878601Q36306413-67E0B4AF-521E-44B2-882E-2520261DDE10
P2860
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Fatty acid analysis of blood p ...... tia, and cognitive impairment.
@ast
Fatty acid analysis of blood p ...... tia, and cognitive impairment.
@en
type
label
Fatty acid analysis of blood p ...... tia, and cognitive impairment.
@ast
Fatty acid analysis of blood p ...... tia, and cognitive impairment.
@en
prefLabel
Fatty acid analysis of blood p ...... tia, and cognitive impairment.
@ast
Fatty acid analysis of blood p ...... tia, and cognitive impairment.
@en
P2093
P921
P1433
P1476
Fatty acid analysis of blood p ...... tia, and cognitive impairment.
@en
P2093
P2888
P304
P356
10.1007/S11745-000-0646-3
P577
2000-12-01T00:00:00Z
P6179
1018194452